The Enterprise Value as of December 2024 (TTM) for Evogene Ltd. (EVGN) is 7.20M

According to Evogene Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.20M. This represents a change of -97.43% compared to the average of 280.51M of the last 4 quarters.

Evogene Ltd. (EVGN) Historical Enterprise Value (quarterly & annually)

How has EVGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Evogene Ltd. over the last ten years is 9.24B. The current 7.20M Enterprise Value has changed -92.21% with respect to the historical average. Over the past ten years (40 quarters), EVGN's Enterprise Value was at its highest in in the September 2017 quarter at 110.80B. The Enterprise Value was at its lowest in in the September 2024 quarter at -311000.00.

Evogene Ltd. (EVGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Evogene Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evogene Ltd. (EVGN) Average Enterprise Value

How has EVGN Enterprise Value performed in the past?

The current Enterprise Value of Evogene Ltd. (EVGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evogene Ltd. (EVGN) Enterprise Value vs. Peers

How is EVGN’s Enterprise Value compared to its peers?

Evogene Ltd.’s Enterprise Value is less than Arcus Biosciences, Inc. (1.31B), less than Fate Therapeutics, Inc. (250.13M), less than Surface Oncology, Inc. (70.21M), less than Pluri Inc. (52.05M), less than Lexaria Bioscience Corp. (32.21M), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than ZyVersa Therapeutics, Inc. (2.57M), less than Biodexa Pharmaceuticals Plc (789.93M), less than Oncorus, Inc. (42.71M), less than Can-Fite BioPharma Ltd. (9.62M), less than ImmuCell Corporation (52.81M), less than Compugen Ltd. (138.99M), less than CollPlant Biotechnologies Ltd. (27.97M), less than Protalix BioTherapeutics, Inc. (0), less than Corvus Pharmaceuticals, Inc. (108.61M), less than Aldeyra Therapeutics, Inc. (310.53M), less than Gamida Cell Ltd. (270.65M), less than Checkpoint Therapeutics, Inc. (57.65M), less than null (170.50M),

Build a custom stock screener for Evogene Ltd. (EVGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evogene Ltd. (EVGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.